Key Insights

Highlights

Success Rate

60% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 90/100

Termination Rate

33.3%

2 terminated out of 6 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

60% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
P 3 (1)

Trial Status

Completed3
Terminated2
Withdrawn1

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (6)

Research Network

Activity Timeline